Peter Guenter

Member of the Executive Board | CEO Healthcare

Peter Guenter is a member of the Executive Board and CEO of Healthcare at Merck KGaA, Darmstadt, Germany. When he started in January 2021, he set a clear strategy with the ambition to outperform the pharmaceutical market. He is aiming for leadership where the business is strong and focusing on key innovations to address high unmet medical needs. Under hisleadership more than 17,500 employees are driven by a common purpose to help create, improve, and prolong lives – as one for patients.

Before joining us, Peter served as CEO of the biopharmaceutical company Almirall, based in Barcelona, Spain, from 2017 to 2020. In this time, he led a strategic and cultural transformation to build a global skin-health focused company and brought the business back on track for growth. Prior to this, Peter worked at Sanofi for 22 years where he was a member of the Executive Committee since 2013. During his tenure there, Peter held a range of local, regional, and global leadership roles and was among other things responsible for Global Commercial Operations.

Peter is a Member of the Board of the European Federation of Pharmaceutical Industries and Associations (EFPIA) where he also took over as the Chair of the Innovation Board Sponsored Committee (BSC) in January 2023. Peter Guenter was born in 1962 in Ghent, Belgium. He holds a Master’s degree in Physical Education from the Faculty of Medicine and Health Sciences of the University of Ghent.

External positions

  • Galapagos N.V., Mechelen, Belgium (publicly listed company), Non-Executive Independent Director
  • Zentiva, Prague, Czech Republic, Member of Advisory Committee 


The Curriculum Vitae of the Executive Board Members are updated when changes occur or regularly upon the publication of the invitation to the annual general meeting.

(Updated in: March 2024)